drugset / Trial / NCT03984461

The Combined Use of PRP with Lipoaspirate And/or Bone Marrow Aspirate in Osteoarthritis

NCT03984461 ↗

Phase 2 Recruiting 240 enrolled Dr. Grant M. Pagdin
RandomizedParallel-groupOpen-labelTreatment

Summary

To demonstrate the efficacy of the combined use of platelet-rich plasma (PRP) with lipoaspirate and/or bone marrow aspirate in osteoarthritis of major joints, and to compare the outcomes achieved using three combinations: PRP plus lipoaspirate, PRP plus bone marrow aspirate, and PRP plus both lipoaspirate and bone marrow aspirate.

Timeline

Start
2020-09-01
Primary completion
2027-12
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Autologous cell therapy Cell therapy — —

Indications